Skip to main content
OpenTrials

Clinical trial condition

Stage IV Breast Cancer

Explore clinical trials studying Stage IV Breast Cancer. Study availability and eligibility vary by location and protocol.

142 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Breast Cancer trial results

Completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

NCT03455270

Conditions
Adenocarcinoma, Advanced Breast Cancer, Breast Cancer, +16 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Stanford Women Cancer Center Stanford, California, United States
  • Northwestern University - Feinberg School of Medicine Chicago, Illinois, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View all 15 locations
View Trial Details
Completed

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

NCT02206334

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 78 locations
View Trial Details
Completed

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

NCT01730833

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope- South Pasadena Cancer Center South Pasadena, California, United States
View Trial Details
Completed

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

NCT03206203

Conditions
Breast Diseases, Breast Neoplasms, HER2 Negative, +8 more
Locations
  • Georgetown University Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Indiana University Health Melvin Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details

Related conditions